M30.0

Clinical Causes: Underlying autoimmune response: The body's immune system mistakenly attacks blood vessel walls. Infections: Certain viruses and bacteria, such as hepatitis B or C, have been linked to the development of PAN. Genetic factors: Although less common, genetic predispositions may play a role. Medication reactions: Rarely, adverse reactions to medications can trigger vasculitis. Environmental exposures: Some environmental factors might contribute, though evidence remains inconclusive.

Key Symptoms: Fever that persists over time Unexplained weight loss Fatigue and weakness Muscle and joint pain Abdominal pain or nausea Skin manifestations: livedo reticularis (a mottled skin appearance), ulcers, or nodules Nerve problems: numbness, tingling, or weakness High blood pressure or kidney issues Potential organ-specific symptoms depending on affected areas, such as neurological deficits or gastrointestinal symptoms

Diagnosis Path: Diagnosis of polyarteritis nodosa involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests may reveal markers of inflammation, such as elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Serology tests for hepatitis B and C are usually performed, given their association with PAN. Biopsies of affected tissues, especially skin or muscle, can confirm blood vessel inflammation. Imaging studies like angiography help visualize aneurysms or narrowed arteries. In some cases, additional tests such as nerve conduction studies or organ-specific assessments might be necessary to evaluate the extent of involvement.

Treatment Protocols: Managing polyarteritis nodosa typically involves immunosuppressive medications to reduce inflammation and control immune system activity. Common treatments include corticosteroids, such as prednisone, to quickly suppress inflammation. For more severe or resistant cases, additional immunosuppressants like cyclophosphamide may be prescribed. Managing associated infections, particularly hepatitis B or C, is essential, often requiring antiviral therapy. Supportive care might include medications to manage symptoms, blood pressure control, and lifestyle adjustments. Regular monitoring is vital to assess treatment response and detect potential complications early. In some instances, plasmapheresis or removal of immune complexes may be considered, especially in severe cases.